Drug · DIN 02018160
CYCLOMEN
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since February 6, 2009; first marketed December 31, 1972.
- Drug Identification Number (DIN)
- 02018160
- Company (DIN owner)
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Danazol G03XA01
- Class
- Human
- Record last updated
- June 12, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DANAZOL | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 18, 2006: NOC 7883New Drug Submission (NDS) · Manufacturer name change
- October 24, 2000: NOC 1085New Drug Submission (NDS)
Other DINs named CYCLOMEN
- DIN 02018152 · Marketed
- DIN 02018144 · Cancelled Post Market